Literature DB >> 11027904

Pain responses in methadone-maintained opioid abusers.

P Compton1, V C Charuvastra, K Kintaudi, W Ling.   

Abstract

Providing pain management for known opioid abusers is a challenging clinical task, in part because little is known about their pain experience and analgesic requirements. This study was designed to describe pain tolerance and analgesic response in a sample of opioid addicts stabilized in methadone-maintenance (MM) treatment (n = 60) in comparison to matched nondependent control subjects (n = 60). By using a placebo-controlled, two-way factorial design, tolerance to cold-pressor (CP) pain was examined, both before and after oral administration of therapeutic doses of common opioid (hydromorphone 2 mg) and nonsteroidal anti-inflammatory (ketorolac 10 mg) analgesic agents. Results showed that MM individuals were significantly less tolerant of CP pain than control subjects, replicating previous work. Analgesic effects were significant neither for medication nor group. These data indicate that MM opioid abusers represent a pain-intolerant subset of clinical patients. Their complaints of pain should be evaluated seriously and managed aggressively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027904     DOI: 10.1016/s0885-3924(00)00191-3

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  41 in total

1.  Hepatitis C virus infection is associated with painful symptoms in HIV-infected adults.

Authors:  Judith I Tsui; Debbie M Cheng; Howard Libman; Carly Bridden; Jeffrey Samet
Journal:  AIDS Care       Date:  2012-01-24

2.  Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain.

Authors:  Jane M Liebschutz; Richard Saitz; Roger D Weiss; Tali Averbuch; Sonia Schwartz; Ellen C Meltzer; Elizabeth Claggett-Borne; Howard Cabral; Jeffrey H Samet
Journal:  J Pain       Date:  2010-03-24       Impact factor: 5.820

Review 3.  Acute pain management for patients receiving maintenance methadone or buprenorphine therapy.

Authors:  Daniel P Alford; Peggy Compton; Jeffrey H Samet
Journal:  Ann Intern Med       Date:  2006-01-17       Impact factor: 25.391

4.  Chronic pain and hepatitis C virus infection in opioid dependent injection drug users.

Authors:  Judith I Tsui; Debra S Herman; Malyna Kettavong; Bradley J Anderson; Michael D Stein
Journal:  J Addict Dis       Date:  2011-04

5.  An assessment of factorial structure and health-related quality of life in problem drug users using the Short Form 36 Health Survey.

Authors:  Angela Buchholz; Anneke Krol; Fred Rist; Pythia T Nieuwkerk; Gerard M Schippers
Journal:  Qual Life Res       Date:  2008-07-12       Impact factor: 4.147

6.  Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders.

Authors:  Judith I Tsui; Marlene C Lira; Debbie M Cheng; Michael R Winter; Daniel P Alford; Jane M Liebschutz; Jianren Mao; Robert R Edwards; Jeffrey H Samet
Journal:  Drug Alcohol Depend       Date:  2015-05-22       Impact factor: 4.492

7.  Hyperalgesia in heroin dependent patients and the effects of opioid substitution therapy.

Authors:  Peggy Compton; Catherine P Canamar; Maureen Hillhouse; Walter Ling
Journal:  J Pain       Date:  2012-03-15       Impact factor: 5.820

8.  Abnormal pain response in pain-sensitive opiate addicts after prolonged abstinence predicts increased drug craving.

Authors:  Zhen-Yu Ren; Jie Shi; David H Epstein; Jun Wang; Lin Lu
Journal:  Psychopharmacology (Berl)       Date:  2009-01-27       Impact factor: 4.530

9.  Reduced cold pain tolerance in chronic pain patients following opioid detoxification.

Authors:  Jarred Younger; Peter Barelka; Ian Carroll; Kim Kaplan; Larry Chu; Ravi Prasad; Ray Gaeta; Sean Mackey
Journal:  Pain Med       Date:  2008-06-18       Impact factor: 3.750

Review 10.  Medical and psychological risks and consequences of long-term opioid therapy in women.

Authors:  Beth D Darnall; Brett R Stacey; Roger Chou
Journal:  Pain Med       Date:  2012-08-20       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.